Works by Londhe, Anil


Results: 17
    1

    Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma.

    Published in:
    EJHaem, 2022, v. 3, n. 1, p. 97, doi. 10.1002/jha2.312
    By:
    • Martin, Thomas;
    • Krishnan, Amrita;
    • Yong, Kwee;
    • Weisel, Katja;
    • Mehra, Maneesha;
    • Nair, Sandhya;
    • Qi, Keqin;
    • Londhe, Anil;
    • Diels, Joris;
    • Crivera, Concetta;
    • Jackson, Carolyn C.;
    • Olyslager, Yunsi;
    • Vogel, Martin;
    • Schecter, Jordan M.;
    • Banerjee, Arnob;
    • Valluri, Satish;
    • Usmani, Saad Z.;
    • Berdeja, Jesus G.;
    • Jagannath, Sundar
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 9, p. 2122, doi. 10.1080/10428194.2019.1579322
    By:
    • Horvath, Noemi;
    • Spencer, Andrew;
    • Kenealy, Melita;
    • Joshua, Douglas;
    • Campbell, Philip J;
    • Lee, Je-Jung;
    • Hou, Jian;
    • Qiu, Lugui;
    • Kalff, Anna;
    • Khong, Tiffany;
    • Londhe, Anil;
    • Siggins, Sarah;
    • van Kooten Losio, Maximiliano;
    • Eisbacher, Michael;
    • Prince, H. Miles
    Publication type:
    Article
    9
    10
    11
    12
    13

    Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.

    Published in:
    Clinical Drug Investigation, 2022, v. 42, n. 1, p. 29, doi. 10.1007/s40261-021-01100-y
    By:
    • Weisel, Katja;
    • Martin, Thomas;
    • Krishnan, Amrita;
    • Jagannath, Sundar;
    • Londhe, Anil;
    • Nair, Sandhya;
    • Diels, Joris;
    • Vogel, Martin;
    • Schecter, Jordan M.;
    • Banerjee, Arnob;
    • Berdeja, Jesus G.;
    • Nesheiwat, Tonia;
    • Garrett, Ashraf;
    • Qi, Keqin;
    • Valluri, Satish;
    • Usmani, Saad Z.;
    • Yong, Kwee
    Publication type:
    Article
    14
    15

    Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 385, doi. 10.1016/j.clml.2023.02.006
    By:
    • Mateos, María-Victoria;
    • Chari, Ajai;
    • Usmani, Saad Z.;
    • Goldschmidt, Hartmut;
    • Weisel, Katja;
    • Qi, Keqin;
    • Londhe, Anil;
    • Nair, Sandhya;
    • Lin, Xiwu;
    • Pei, Lixia;
    • Ammann, Eric;
    • Kobos, Rachel;
    • Smit, Jennifer;
    • Parekh, Trilok;
    • Marshall, Alexander;
    • Slavcev, Mary;
    • Moreau, Philippe
    Publication type:
    Article
    16
    17